Back to List View Graph View

Cancer-associated fibroblast

Cancer-associated fibroblasts (CAFs) are activated stromal fibroblasts that reside within the tumor microenvironment and play a central role in promoting malignant progression and therapeutic resistance.

Where the papers sit

11 papers from the last 6 months study cancer-associated fibroblast directly · updated from PubMed 14 Nov 2026

Study type 0 clinical trials · 2 observational · 2 human data · 5 preclinical · 2 unclassified

Themes 3 themes · 1 new direction

  • Stromal Drivers of Resistance

    CAF-driven metabolic remodeling is a recurrent explanation for treatment resistance across pancreatic, liver, and breast cancers. Mitophagy can rewire pyrimidine supply in pancreatic cancer, while WNK4-associated cysteine metabolism supports anti-PD-1 resistance in hepatocellular carcinoma. Spatial profiling of hepatic stellate cells and CAFs and ligand–receptor models connect stromal states with prognosis. Dual tumor–stroma delivery offers a route to overcome resistance, but shared mechanisms across cancers remain unresolved.

    5 papers · 45.5%

  • CAF-Mediated Immune Exclusion

    THY1- and CTGF+ CAF programs are linked to hypoxia, tumor–stroma crosstalk, and immune exclusion. TGF-beta-associated endothelial barriers recur with reduced immune-cell access and checkpoint resistance. Transcriptomic and machine-learning analyses increasingly prioritize CAF infiltration regulators as therapeutic targets. Whether disrupting these CAF states improves checkpoint response remains open.

    3 papers · 27.3%

  • CAF Heterogeneity and Prognosis

    CAF heterogeneity is being linked to prognosis and treatment failure rather than treated as a single cell state. Pericyte-derived CAFs in glioblastoma are enriched after chemoradiotherapy and correlate with poor survival, while invasion-front CAFs predict outcome in oral squamous cell carcinoma. Mixed CAF populations can limit FAP-CD3 T-cell engager efficacy. Spatial and lineage-informed biomarker studies may clarify which CAF states are actionable.

    3 papers · 27.3%

NEW DIRECTION

In glioblastoma, cancer-associated fibroblasts may be a pericyte-derived transcriptional state rather than a conventional fibroblast population

The glioblastoma study, examining single-cell and bulk datasets to determine the identity and origin of CAFs in a brain tumor, challenges the assumption that CAFs are a distinct fibroblast population: it found a continuous transcriptional spectrum linking endothelial cells, pericytes, and CAFs, with pericytes the most likely source, despite the absence of fibroblasts from normal brain parenchyma. This assigns CAFs a role as a perivascular cell state that can emerge in the tumor context, changing interpretation of CAF signatures and the rationale for targeting them in glioblastoma 42721145Sep.

Papers

The 11 papers from the last 6 months that study cancer-associated fibroblast directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.

By theme

Stromal Drivers of Resistance (5)
  1. Dynamic subpopulations and spatial interactions of hepatic stellate cells and cancer-associated fibroblasts in liver cancer. Acta biochimica et biophysica Sinica · 14 Aug 2026 PMID 42599778
  2. Dual-cargo polymeric micelles with tumor-cell/stroma dual-targeting for synergistic eradication of drug-resistant breast cancer. Biomaterials science · 10 Aug 2026 PMID 42572978
  3. Improving pancreatic adenocarcinoma prognosis models through ligand receptor interactions and histopathological integration. Journal of translational medicine · 3 Jul 2026 PMID 42399741
  4. WNK4 Enhances Anti-PD-1 Resistance and Promotes Tumor Progression in Hepatocellular Carcinoma by Reprogramming Cysteine Metabolism in Cancer-Associated Fibroblasts. FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 8 Jun 2026 PMID 42253146
  5. Mitophagy-Competent Cancer-Associated Fibroblasts Fuel Chemoresistance by Rewiring Pyrimidine Metabolism in Pancreatic Cancer. Cancer research · 27 May 2026 PMID 42202065
CAF-Mediated Immune Exclusion (3)
  1. A recurrent cancer-associated fibroblast/TGF-beta/endothelial barrier direction is associated with immune exclusion and checkpoint resistance in bladder cancer: a public multi-cohort transcriptomic study. PloS one · 22 Sept 2026 PMID 42771603
  2. Targeting CTGF+ cancer-associated fibroblasts disrupts tumor-stroma crosstalk in pancreatic ductal adenocarcinoma. Proceedings of the National Academy of Sciences of the United States of America · 2 Sept 2026 PMID 42685072
  3. Integrated Transcriptomic Analysis and Machine Learning Identify THY1 as a Key Regulator of Cancer-Associated Fibroblast Infiltration, Promoting Malignant Progression and Immune Escape in Gastric Cancer. Journal of gastroenterology and hepatology · 22 Aug 2026 PMID 42629612
CAF Heterogeneity and Prognosis (3)
  1. Pericyte-derived cancer-associated fibroblasts correlate with poor survival and are enriched after chemoradiotherapy in glioblastoma. PloS one · 10 Sept 2026 PMID 42721145
  2. Emergence of a mixed CAF population by FAP-CD3 T-cell engager limits therapeutic efficacy. Journal for immunotherapy of cancer · 3 Jul 2026 PMID 42398971
  3. Cancer-Associated Fibroblasts in Invasion Front Can be a Prognostic Predictor for Oral Squamous Cell Carcinoma. Pathology international · 1 Jun 2026 PMID 42219817

By study type

Observational studies and case reports (2)
  1. A recurrent cancer-associated fibroblast/TGF-beta/endothelial barrier direction is associated with immune exclusion and checkpoint resistance in bladder cancer: a public multi-cohort transcriptomic study. PloS one · 22 Sept 2026 PMID 42771603
  2. Cancer-Associated Fibroblasts in Invasion Front Can be a Prognostic Predictor for Oral Squamous Cell Carcinoma. Pathology international · 1 Jun 2026 PMID 42219817
Human data, design not indexed (2)
  1. Pericyte-derived cancer-associated fibroblasts correlate with poor survival and are enriched after chemoradiotherapy in glioblastoma. PloS one · 10 Sept 2026 PMID 42721145
  2. Integrated Transcriptomic Analysis and Machine Learning Identify THY1 as a Key Regulator of Cancer-Associated Fibroblast Infiltration, Promoting Malignant Progression and Immune Escape in Gastric Cancer. Journal of gastroenterology and hepatology · 22 Aug 2026 PMID 42629612
Preclinical: animal, cell and lab studies (5)
  1. Targeting CTGF+ cancer-associated fibroblasts disrupts tumor-stroma crosstalk in pancreatic ductal adenocarcinoma. Proceedings of the National Academy of Sciences of the United States of America · 2 Sept 2026 PMID 42685072
  2. Dual-cargo polymeric micelles with tumor-cell/stroma dual-targeting for synergistic eradication of drug-resistant breast cancer. Biomaterials science · 10 Aug 2026 PMID 42572978
  3. Emergence of a mixed CAF population by FAP-CD3 T-cell engager limits therapeutic efficacy. Journal for immunotherapy of cancer · 3 Jul 2026 PMID 42398971
  4. WNK4 Enhances Anti-PD-1 Resistance and Promotes Tumor Progression in Hepatocellular Carcinoma by Reprogramming Cysteine Metabolism in Cancer-Associated Fibroblasts. FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 8 Jun 2026 PMID 42253146
  5. Mitophagy-Competent Cancer-Associated Fibroblasts Fuel Chemoresistance by Rewiring Pyrimidine Metabolism in Pancreatic Cancer. Cancer research · 27 May 2026 PMID 42202065
Unclassified: not yet indexed with MeSH (2)
  1. Dynamic subpopulations and spatial interactions of hepatic stellate cells and cancer-associated fibroblasts in liver cancer. Acta biochimica et biophysica Sinica · 14 Aug 2026 PMID 42599778
  2. Improving pancreatic adenocarcinoma prognosis models through ligand receptor interactions and histopathological integration. Journal of translational medicine · 3 Jul 2026 PMID 42399741